Literature DB >> 3594475

Structural studies of the capsular polysaccharide from Streptococcus pneumoniae types 15B and 15C.

P E Jansson, B Lindberg, U Lindquist, J Ljungberg.   

Abstract

The structures of the capsular polysaccharides (S-15B and S-15C) from Streptococcus pneumoniae types 15B and 15C have been investigated by using n.m.r. spectroscopy, methylation analysis, and various specific degradations. It is concluded that the polysaccharides are composed of pentasaccharide repeating-units having the following structure: (Formula: see text). In this structure, R is H (80%) or CH2CH2N+Me3 (20%). S-15B further contains O-acetyl groups, approximately 0.7 per repeating unit, which have not been located. The capsular polysaccharides S-15F and S-15A, which have been studied previously, are also composed of pentasaccharide repeating-units, containing the same sequence of sugars, but in a linear arrangement.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3594475     DOI: 10.1016/0008-6215(87)80205-7

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  8 in total

1.  The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.

Authors:  Brady L Spencer; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides.

Authors:  Saskia van Selm; Lisette M van Cann; Marc A B Kolkman; Bernard A M van der Zeijst; Jos P M van Putten
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

4.  Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C.

Authors:  Gowrisankar Rajam; George M Carlone; Sandra Romero-Steiner
Journal:  Clin Vaccine Immunol       Date:  2007-07-03

Review 5.  Enzymatic modifications of exopolysaccharides enhance bacterial persistence.

Authors:  Gregory B Whitfield; Lindsey S Marmont; P Lynne Howell
Journal:  Front Microbiol       Date:  2015-05-15       Impact factor: 5.640

6.  External Quality Assurance for Laboratory Identification and Capsular Typing of Streptococcus pneumoniae.

Authors:  Hans-Christian Slotved; Carmen L Sheppard; Tine Dalby; Arie van der Ende; Norman K Fry; Eva Morfeldt; Outi Nyholm; Assaf Rokney; Merav Ron; Lotta Siira; Kevin J Scott; Andrew Smith; Louise Thom; Maija Toropainen; Didrik F Vestrheim
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

7.  Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine.

Authors:  Alison S Laufer; Jonathan C Thomas; Marisol Figueira; Janneane F Gent; Stephen I Pelton; Melinda M Pettigrew
Journal:  Vaccine       Date:  2010-01-10       Impact factor: 3.641

8.  Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes.

Authors:  Stephen D Bentley; David M Aanensen; Angeliki Mavroidi; David Saunders; Ester Rabbinowitsch; Matthew Collins; Kathy Donohoe; David Harris; Lee Murphy; Michael A Quail; Gabby Samuel; Ian C Skovsted; Margit Staum Kaltoft; Bart Barrell; Peter R Reeves; Julian Parkhill; Brian G Spratt
Journal:  PLoS Genet       Date:  2006-03-10       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.